Latest Security News

Valiant Gold Limited (ASX: VAL) has successfully listed on the ASX, raising $75 million before costs, and is progressing its Comet and Reedy gold projects with key operational milestones underway.

Buxton Resources has secured all key approvals to start drilling at its Madman Project and agreed to sell its 49% interest in the Copper Wolf JV to IGO for about A$6.15 million, shifting its focus to Australian exploration.

American West Metals reported a 20% increase in contained copper at its Storm Copper Project and intersected promising skarn mineralisation in initial West Desert drilling, highlighting significant exploration upside across its North American base metals portfolio.

Canterbury Resources has kicked off an extensive drilling campaign at its flagship Briggs Copper Project as part of a Pre-feasibility Study, while securing the Monto Project with promising copper-molybdenum resources. High-grade assays from PNG’s Ekuti Range reaffirm the company’s regional exploration potential.

Estrella Resources has initiated Timor-Leste’s inaugural hard rock mineral extraction at its Ira Miri manganese project, advancing towards full-scale mining and simultaneously progressing a major limestone resource at Werumata.

Australian Strategic Materials reports a 70% surge in NdFeB alloy production, installs pilot heavy rare earth furnace, and progresses its acquisition by Energy Fuels with regulatory approvals underway.

Top End Energy is progressing farm-out talks in the Beetaloo Basin amid growing industry validation, while its Kansas hydrogen project attracts new partners and it broadens into US AI data centre energy solutions.

Meteoric Resources has reported strong pilot plant performance and advanced feasibility work at its Caldeira rare earths project, alongside a $50 million non-binding financing letter from Export Finance Australia and robust Brazilian government backing.

xReality Group delivered a standout Q3 FY26 with a 62% jump in cash receipts and a new Mixed Reality sale to the US Department of Defense, underpinning its growing Operator XR platform.

Epiminder has ramped up enrolment in its DETECT study, contracting 18 US medical centres and maintaining a robust $83.8 million cash position to fund its Minder device commercialisation through 2028.

ImpediMed reported a $3.5 million revenue in Q3 FY26, with reimbursement coverage in the US reaching 94.3%, supporting growth in heart health and weight management markets. New CEO Erik Anderson aims to accelerate commercial momentum and drive cash flow break-even.

AVADA Group reported a 14.9% rise in cash receipts for Q1 2026, underpinned by strong sales in Queensland and New South Wales, while completing a refinancing that improves liquidity and covenant headroom.